About the Speaker
Dr Troy Grennan, MD MSc FRCPC
Physician Lead, HIV/STI Program
BC Centre for Disease Control
Dr. Troy Grennan is the Physician Lead of the HIV/STI Program at the BC Centre for Disease Control, and a Clinical Associate Professor in the Department of Medicine at the University of British Columbia. He is an infectious diseases physician and researcher, where both his clinical and research work focus on sexually transmitted infection (STI) treatment and prevention, HIV, HPV and anal cancer screening, and the health of gay, bisexual and other men who have sex with men (gbMSM). Dr. Grennan holds a Health Professional-Investigator Award from Michael Smith Health Research BC, is Vice-Chair of the Public Health Agency of Canada’s National Advisory Committee on Sexually Transmitted and Bloodborne Infections, and Regional Co-Lead of the CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research. He currently is Co-Principal Investigator on two large Canadian studies: the PEACH study, an anal cancer screening study examining novel biomarkers in persons living with HIV, and the DISCO study, a randomized controlled trial of doxycycline pre- and post-exposure prophylaxis for STI prevention.
Speaker Sessions
- EST
- Auditorium
- In-Person
Oral Abstracts - Research Forum 1 - Non-CME
- HSIL Risk After Negative Screening - Kirsten Rozemeijer
- Deep Learning and HPV Pleomorphic Multiorgans Induced Lesions: Automated Detection and Differentiation of Cervical and Anal Squamous Cancers Precursors - Miguel Mascarenhas
- Feminizing Gender-Affirming Hormone Therapy, HPV, and Precancerous Anal Lesions in High-Risk Populations: A Systematic Review - Manuel Valencia Echeverria
- Psychosocial Factors Associated with HPV Infection in Transgender Women in Argentina - Luciana La Rosa
- Risk Factors for Anal Human Papillomavirus (HPV) Infection and Anal HSIL Among Older Gay, Bisexual and Other Men Who Have Sex with Men (GBMSM) - Alexandra Hernandez
- Improving Screening Strategies for Detecting High-Grade Squamous Intraepithelial Lesions as a Predictor of Anal Cancer - Derek W. Ren
- The Addition of High-Risk HPV Testing as a Triage Tool in Anal Cancer Screening Optimizes the Referral Rate in a Canadian Cohort of Men Who Have Sex with Men Living with HIV - Troy Grennan
- Incidence of Anal High-Grade Squamous Intraepithelial Lesion (HSIL) Is High in Attendees of an Anal Cancer Screening Clinic in Vancouver, Canada: 2003-2021 - Troy Grennan
